Health Catalyst, Inc.
HCAT
$4.16
$0.0451.10%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 41.17% | 35.98% | 41.32% | 28.75% | 14.01% |
| Total Depreciation and Amortization | -5.91% | -8.31% | -12.52% | -17.25% | -18.73% |
| Total Amortization of Deferred Charges | 29.42% | 17.48% | 6.23% | 10.97% | 20.61% |
| Total Other Non-Cash Items | -27.21% | -24.34% | -30.70% | -24.53% | -16.97% |
| Change in Net Operating Assets | 95.17% | -19.14% | 33.34% | 37.29% | 1.70% |
| Cash from Operations | 144.01% | 96.69% | 90.80% | 58.97% | 6.21% |
| Capital Expenditure | -30.74% | -4.44% | 63.05% | 54.43% | 42.96% |
| Sale of Property, Plant, and Equipment | -58.06% | -33.33% | -10.00% | -9.68% | 6.90% |
| Cash Acquisitions | -604.68% | -- | -- | -22.01% | 59.09% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.32% | 9,464.79% | 1,373.42% | 1,549.44% | 463.95% |
| Cash from Investing | -212.86% | 3,655.94% | 846.32% | 552.78% | 152.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.15% | -45.08% | -40.15% | -38.65% | -36.28% |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | 78.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,458.46% | 3,750.98% | 153.43% | 171.31% | 204.48% |
| Foreign Exchange rate Adjustments | -261.90% | 3,100.00% | -118.18% | 40.00% | 290.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,528.55% | 897.72% | 240.64% | 204.53% | 86.95% |
